Oncology PracticeNumber of cancer survivors with functional limitations doubled in 20 yearsMay 11, 2023Patient & Survivor CareLung CancerDiversity in MedicineBreast CancerMixed TopicsLymphoma & Plasma Cell DisordersLeukemia, Myelodysplasia, Transplantation
Hematology NewsAFib risk with cancer drugs underestimatedApril 12, 2023Breast CancerLeukemia, Myelodysplasia, TransplantationLung CancerLymphoma & Plasma Cell DisordersImmuno-oncologyHodgkin LymphomaAML
Hematology NewsAtorvastatin cut anthracycline cardiac dysfunction in lymphomaMarch 4, 2023Hodgkin LymphomaNon-Hodgkin LymphomaLymphoma & Plasma Cell Disorders
Hematology NewsZUMA-5: Axi-cel yields high response rate in indolent NHLDecember 6, 2020B Cell LymphomaLymphoma & Plasma Cell DisordersNon-Hodgkin Lymphoma
Hematology NewsCOVID-19–related outcomes poor for patients with hematologic disease in ASH registryDecember 5, 2020COVID-19 UpdatesALLMultiple MyelomaB Cell LymphomaNon-Hodgkin Lymphoma
Hematology NewsCare coordination, equity can eliminate disparities for nonwhite patients with DLBCLDecember 8, 2019DLBCLLymphoma & Plasma Cell DisordersNon-Hodgkin Lymphoma
Hematology NewsASCO to award $50,000 young investigator grant to study MCLOctober 23, 2019Mantle Cell LymphomaLymphoma & Plasma Cell DisordersNon-Hodgkin Lymphoma
Hematology TimesGroup proposes new grading systems for CRS, neurotoxicityJanuary 3, 2019Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersMultiple MyelomaTransplantationALLNon-Hodgkin LymphomaAggressive Lymphomas
Hematology TimesCombo bests standard care in younger CLL patientsDecember 12, 2018Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersNon-Hodgkin LymphomaAggressive Lymphomas
Hematology TimesFludarabine deemed important for CD30.CAR T-cell therapyDecember 11, 2018Lymphoma & Plasma Cell DisordersHodgkin LymphomaNon-Hodgkin Lymphoma
Hematology TimesMutation confers resistance to venetoclax in CLLDecember 7, 2018Lymphoma & Plasma Cell DisordersNon-Hodgkin LymphomaAggressive LymphomasB Cell Lymphoma
Hematology TimesTwo-drug combo deemed ‘very promising’ for PMBCLDecember 6, 2018Lymphoma & Plasma Cell DisordersNon-Hodgkin LymphomaAggressive Lymphomas
Hematology NewsShorter R-CHOP regimen noninferior in certain DLBCL patientsDecember 5, 2018Lymphoma & Plasma Cell DisordersNon-Hodgkin LymphomaAggressive LymphomasB Cell Lymphoma
Hematology TimesRegimen provides survival benefit in PTCLDecember 4, 2018Lymphoma & Plasma Cell DisordersNon-Hodgkin LymphomaB Cell Lymphoma
Hematology TimesNew PCNSL guidelines emphasize importance of patient fitnessDecember 2, 2018Lymphoma & Plasma Cell DisordersNon-Hodgkin LymphomaAggressive Lymphomas
